Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (FY)Mar 31, 2025 | (FY)Mar 31, 2024 | (Q4)Mar 31, 2024 | (FY)Mar 31, 2023 | (FY)Mar 31, 2022 | |
|---|---|---|---|---|---|
| Total revenue | 8.86%1.39B | 11.51%1.28B | 395.19M | 12.09%1.15B | 1.02B |
| Cost of revenue | 4.73%330.51M | 18.52%315.59M | 111.26M | 8.71%266.27M | 244.94M |
| Gross profit | 10.21%1.06B | 9.39%964.5M | 283.93M | 13.15%881.73M | 779.27M |
| Operating expense | 7.11%817.83M | -2.90%763.54M | 212.94M | 11.09%786.34M | 707.81M |
| Selling and administrative expenses | 7.11%817.83M | -2.90%763.54M | --212.94M | 11.09%786.34M | --707.81M |
| -General and administrative expense | 7.11%817.83M | -2.90%763.54M | --212.94M | 11.09%786.34M | --707.81M |
| Operating profit | 21.97%245.12M | 110.67%200.96M | 70.99M | 33.49%95.39M | 71.46M |
| Net non-operating interest income (expenses) | 105.96%253K | -424,400.00%-4.24M | -4.19M | -75.00%1K | 4K |
| Non-operating interest income | 662.79%328K | 53.57%43K | --6K | -54.84%28K | --62K |
| Non-operating interest expense | -33.04%75K | 314.81%112K | --24K | -53.45%27K | --58K |
| Total other finance cost | ---- | --4.17M | ---- | ---- | ---- |
| Net investment income | -7.00%-2.43M | 1.86%-2.27M | -1.01M | -127.56%-2.32M | 8.4M |
| Gain(Loss) on financial instruments designated as cash flow hedges | |||||
| Gain(Loss) on derecognition of available-for-sale financial assets | -12,028.11%-26.32M | -101.42%-217K | 7.35M | 62.19%15.3M | 9.43M |
| Income from associates and other participating interests | 3,831.93%12.39M | -119.40%-332K | -91K | -5.78%1.71M | 1.82M |
| Special income (charges) | 0 | 222.74%3.33M | 0 | -110.73%-2.71M | 25.28M |
| Less:Other special charges | ---- | -3,368.75%-3.33M | --0 | 99.62%-96K | ---25.28M |
| Less:Write off | --0 | --0 | ---- | --2.81M | --0 |
| Other non-operating income (expenses) | 167.34%3.77M | -1,099.79%-5.59M | -5.41M | -259.04%-466K | 293K |
| Income before tax | 21.47%232.77M | 79.26%191.63M | 67.63M | -8.39%106.9M | 116.69M |
| Income tax | 20.23%88.69M | 414.36%73.76M | 26.3M | -18.19%14.34M | 17.53M |
| Net income | 22.24%144.09M | 27.34%117.87M | 41.33M | -6.66%92.56M | 99.16M |
| Net income continuous operations | 22.24%144.09M | 27.34%117.87M | --41.33M | -6.65%92.56M | --99.16M |
| Noncontrolling interests | -298.10%-33.48M | -195.70%-8.41M | 5.02M | 365.03%8.79M | 1.89M |
| Net income attributable to the company | 40.62%177.57M | 50.74%126.28M | 36.31M | -13.88%83.77M | 97.27M |
| Preferred stock dividends | |||||
| Other under preferred stock dividend | 0 | 0 | 0 | 0 | 0 |
| Net income attributable to common stockholders | 40.62%177.57M | 50.74%126.28M | 36.31M | -13.88%83.77M | 97.27M |
| Gross dividend payment | |||||
| Basic earnings per share | 18.18%92.89 | 50.12%78.6 | 29.7027 | -0.96%52.3575 | 52.8647 |
| Diluted earnings per share | 21.24%91.61 | 44.32%75.56 | 26.6627 | -0.96%52.3575 | 52.8647 |
| Dividend per share | |||||
| Currency Unit | JPY | JPY | JPY | JPY | JPY |
| Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |